At Fierce Healthcare, we keep track of all the venture capital being funneled into the health tech and digital health industries.
Our fundraising tracker provides updated coverage of noteworthy digital health and health tech funding rounds, though we'll still profile exciting new companies and larger rounds that catch our eye in depth.
Do you have fundraising news to share? Email Senior Editor Heather Landi at hlandi@questex.com.
AI-enabled digital health company picks up $107M
Persivia, an artificial-intelligence-driven digital health solution, secured a $107 million investment from Aldrich Capital Partners, a growth equity firm.
With the investment, the company says it will accelerate its expansion plans, significantly grow its sales force over the next 12 months and roll out new AI-powered solutions aimed at improving operational efficiency and patient management.
"This partnership is about more than just capital,” said Mansoor Khan, Ph.D., CEO of Persivia. “It’s about launching a national growth strategy and making our platform the first choice for every healthcare organization that wants clean, actionable data and AI-driven tools to support value based care.”
Persivia’s platform was developed for health systems and payers to help streamline workflows, reduce costs and improve outcomes. It claims to support more than 200 hospitals and 12,000 clinicians nationwide.
The company says it offers a single AI-powered platform that delivers clean, governed data across use cases—from value-based care to population health and quality improvement.
The company also announced the issuance of a new patent for its health data processing system. The newly granted patent protects the core AI capabilities behind CareSpace, Persivia’s modular digital health platform. CareSpace uses Soliton, a now-patented AI engine, to ingest, analyze, prioritize and deliver actionable insights in real time.
Plenful banks $50M for workflow automation
Plenful built an artificial intelligence workflow automation platform to tackle administrative tasks in healthcare. The startup picked up $50 million in series B funding to accelerate product development and go-to-market efforts.
The round was co-led by Mitchell Rales, co-founder of Danaher Corporation, who also joins Plenful's board, and Arena Holdings, with participation from Notable Capital, Bessemer Venture Partners, TQ Ventures, Susa/Kivu Ventures and other leading investors.
Plenful's workflow automation platform handles "messy, disparate workflows across formats, systems, and departments, reducing errors and streamlining operations while providing real-time reporting and task management for healthcare staff," the company said.
The Medical University of South Carolina, Cencora, Renown Health, Shields Healthcare Group and Samaritan Health are among the healthcare organizations that use Plenful's technology. The company says its most widely adopted use cases include prior authorization, 340B compliance and missed opportunity auditing, and order and referral data entry.
With this new funding, the company will expand its platform to address more unmet needs across healthcare, deepening its presence in the pharmacy, health system, provider group and payor markets.
The company says it now works with 60 healthcare organizations and has experienced 4x year-over-year growth.
Plenful has raised $76 million to date.
Health benefits navigation startup scores $50M
Healthee, a company that uses artificial intelligence to help individuals navigate their health benefits, raised $50 million in a series B funding round.
Key1 Capital led the round with backing from Fin Capital, Glilot Capital Partners and Group11.
With the fresh capital, Healthee plans to expand its product suite, scale its go-to-market operations and double down on delivering AI-powered tools for smarter, more accessible health benefits.
Healthee said it did not formally launch the raise. "Key1 Capital approached the team after tracking the company’s traction, believing in the product’s vision and potential. The round was oversubscribed, reflecting strong conviction from new and existing investors," the company said in a blog post.
The company said it had a breakout year, surpassing 15,000 customers including Instacart, SiriusXM and Celonis. Healthee has also deepened its AI capabilities and delivered real savings by improving care access to employers and employees, the company said.
Kaiser Permanente, General Catalyst back AI supply chain startup
Clarium raised $27 million in a series A funding round to fuel its growth as it aims to use artificial intelligence to tackle healthcare supply chains.
The startup says its technology can help mitigate growing economic and environmental uncertainty in the supply chain for suppliers and hospitals.
Northzone led the round, with participation from existing investors including General Catalyst, AlleyCorp, Kaiser Permanente Ventures, Texas Medical Center Ventures and 1984 Ventures. This round brings Clarium's total funding to $43 million to date.
Clarium's $27 million financial investment from Northzone and existing partners will allow the company to accelerate the development and scale of Astra OS—including additional app and solution development—expand its team and develop relationships with new health system partners.
As major weather events, global pandemics and economic tariffs intensify, supply chain vulnerabilities are poised to disrupt critical care operations in hospitals nationwide. Vizient's outlook report projects a 3.84% increase in pharmacy and an increase of 2.3% in non-pharmacy spend over the next year.
Clarium's platform collects, unifies and automates crowdsourced data from providers, suppliers and vendors across the entire healthcare supply chain. It serves as a resiliency platform to help major hospitals and health systems manage their supply chain operations. The company predicts supply chain disruptions based on real-time weather, geopolitical and current events data, providing recommendations for substitutions and preventing major disruptions to productivity and outcomes.
The company currently collaborates with Yale New Haven Health, Geisinger, Ochsner Health and Boston Children's Hospital as well as The Cleveland Clinic, Kaiser Permanente, Sutter Health, St. Luke's and others. Additionally, Clarium has a long-term strategic partnership with the Healthcare Industry Resiliency Collaborative to co-develop transformative technology and data standards.
Blooming Health sprouts with $26M series A round
Social care technology company Blooming Health nabbed $26 million in a series A funding round
Software investor Insight Partners led the round with participation from existing investors Afore Capital, Crossbeam Venture Partners and Metrodora Ventures.
The investment brings Blooming Health's total funding to $32.5 million.
The startup says it has connected more than 1.5 million people across 22 states with needed support, whether it's meal delivery, transportation to a doctor, housing assistance or social activities. Blooming Health plans to automate access to social care through artificial intelligence. The company's solution uses a social care AI agent and an automated social care marketplace to streamline the way individuals find and receive critical social services.
The AI agent engages directly with people, often older adults and vulnerable populations, via text or phone, helping identify needs and connecting them to services in seconds. The company also helps 1,000 community organizations, government agencies and healthcare providers more effectively reach and manage their populations at scale.
The company says it will use the fresh funds to rapidly scale operations to reach 10 million people within the next 12 months, expanding Blooming Health's presence nationwide. The company will also deepen partnerships with state and local governments, healthcare systems and community-based organizations to integrate social care into broader healthcare delivery.
"By putting AI at the core of our solution, we can proactively reach out to millions of people and connect them with services in ways that simply weren't possible before," Nima Roohi, co-founder and CEO of Blooming Health, said in a statement.
Carta Healthcare picks up $18.25M to expand AI clinical data platform
Carta Healthcare secured $18.25 million in series B1 funding to accelerate its growth and build out its artificial-intelligence-powered data abstraction platform.
Demand among health systems and life sciences organizations is growing for AI-driven solutions that turn clinical data into valuable insights, according to the company.
UPMC Enterprises led the round, with participation from new strategic investors including MemorialCare Innovation Fund, Rex Health Ventures (the investment fund for the UNC Health), Tampa General Hospital Ventures and support from existing investors Memorial Hermann Health System, Frist Cressey Ventures, Storm Ventures, Paramark Ventures, CU Healthcare Innovation Fund and Mass General Brigham Ventures.
The new funding will enable Carta Healthcare to further expand its growing customer footprint, particularly in the life sciences market. The funding round comes on the heels of the company's late 2024 acquisition of Realyze Intelligence Intelligence from UPMC Enterprises. Realyze Intelligence’s technology uses AI to rapidly analyze structured and unstructured data and identify specific patients that match clinical trials and other research studies.
Founded in 2017, Carta Healthcare developed a platform that combines AI, machine learning and deep clinical expertise to automate the collection and analysis of clinical data, enabling healthcare organizations to generate actionable insights that drive quality improvement initiatives.
“We’ve demonstrated consistent year-over-year growth by focusing on delivering measurable value to healthcare systems,” Carta Healthcare Chief Financial Officer Lucas Tanner said in a statement. "This new capital will allow us to scale our team and infrastructure to meet increasing market demand. With a strengthened balance sheet and critical insights from industry-leading strategic investors, we are well-positioned to capture the significant market opportunity ahead of us.”
Oncology care startup nab $16M seed round
Health tech startup Complement 1 developed a tech-enabled, clinically validated lifestyle modification platform for cancer patients and high-risk individuals.
The company secured a $16 million seed funding round led by Owl Ventures and Blume Ventures. Complement 1, which emerged out of stealth, said the seed round was oversubscribed.
Research shows that improvements in diet, physical activity, stress management and other behaviors can significantly reduce cancer recurrence and mortality—by 35% and 37%, respectively—and boost patients’ quality of life.
Complement 1 offers personalized, daily guidance and education to individuals through one-on-one dedicated CoActive Coaches. The company focused on evidence-based interventions related to physical activity, nutrition and somatic practices, customized for cancer type and stage, delivered by dedicated CoActive 1:1 Coaches.
As validated by clinical trials, Complement 1 members report 37% fewer treatment side effects, 18% less pain and 27% better sleep—all while achieving an over 90% adherence rate among users. Meanwhile, the platform helps health plans, employers and providers reduce costs for cancer patients—by up to 30%, according to the company.
The platform’s evidence backed, medically validated rule engine tailors the program to each individual’s cancer type, treatment stage, side-effect profile and personal preferences, leveraging guidelines developed by leading oncologists and in partnership with the American Institute for Cancer Research.
With the new capital, Complement 1 plans to scale up its coaching infrastructure and operations across the U.S. as well as to advance its AI-driven personalization engine. The company also plans to partner with cancer centers, health plans and employers to expand the program. It will also invest in product development to enhance the digital user experience for both patients and coaches.
Olio nabs $11M to build out care coordination solution
Olio picked up $11 million in series B funding round to expand its product offerings and accelerate go-to-market initiatives,.
Olio's technology enables payers, health systems and physician groups to manage patient transitions across care settings: skilled nursing, home health, behavioral health and long-term care.
The round was led by Fulcrum Equity Partners with participation from Mutual Capital Partners, a growth equity firm specializing in scaling innovative healthcare and B2B software companies.
Ascertain picks up $10M to scale agentic AI for healthcare
Health tech startup Ascertain picked up $10 million in series A funding to build out its agentic artificial intelligence tech for health systems, payers and provider groups.
Deerfield Management led the financing round with strategic participation from Northwell Health. The investment will accelerate the growth and expand access to Ascertain's AI-powered solutions, the startup said.
Ascertain was launched by Northwell Holdings, the for-profit investment arm of Northwell Health, and Aegis Ventures.
The company's AI-powered case management solution automates time-consuming workflows, enabling case managers to focus more on improving the quality and efficiency of patient care, according to the company. Ascertain uses AI to tackle administrative tasks such as documentation, prior authorizations and compliance with aim of boosting efficiency and enable understaffed teams to operate more effectively.
The company uses AI to "reimagine healthcare workflows from the ground up, rather than just making existing workflows more efficient," Julian Harris, M.D., operating partner, healthcare services at Deerfield Management, said in a statement.
Customers can either deploy Ascertain Automate, an enterprise software platform that uses agentic AI to automate high-volume administrative workflows, or engage Ascertain's tech-enabled services, outsourcing entire workflows to Ascertain's team, which operates the software on their behalf.
Northwell Health has been piloting the technology, in partnership with the health system's centralized transitions-of-care administration team, to process authorizations. The initiative has generated strong results, according to the startup, enabling nurses, case managers, social workers and other staff to focus more of their time on patient care rather than administrative tasks.
"Building on the experience with Northwell, Ascertain is well positioned to partner with fellow health systems to drive greater efficiency and improve patient care," said Mark Solazzo, president of strategic initiatives and chief operating officer at Northwell Health, in a statement.
Northwell Health is a member of the Aegis Digital Consortium, a collaboration of 11 health systems to develop and scale AI-enabled technology solutions.